BACKGROUND: The relative immunogenicity of human immunodeficiency virus type 1 (HIV-1) proteins for CD8+ and CD4+ cell responses has not been defined. METHODS: HIV-1-specific T cell responses were evaluated in 65 chronically HIV-1-infected untreated subjects by interferon- gamma flow cytometry with peptides spanning the clade C consensus sequence. RESULTS: The magnitude of HIV-1-specific CD8+ T cell responses correlated significantly with CD4+ cell responses, but the percentage of CD8+ T cells directed against HIV-1 (median, 2.76%) was always greater than that of CD4+ cells (median, 0.24%). Although CD8+ T cell responses were equally distributed among Gag, Pol, and the regulatory and accessory proteins, Gag was the dominant target for CD4+ cell responses. There was no consistent relationship between virus-specific CD8+ or CD4+ cell response and viral load. However, the median viral load in subjects in whom Gag was the dominant CD8+ T cell target was significantly lower than that in subjects in whom non-Gag proteins were the main target (P=.007). CONCLUSIONS: Gag-specific responses dominate the CD4+ T cell response to HIV, whereas CD8+ T cell responses are broadly distributed, which indicates differential immunogenicity of these cells against HIV-1. The preferential targeting of Gag by CD8+ T cells is associated with enhanced control of viral load.
BACKGROUND: The relative immunogenicity of human immunodeficiency virus type 1 (HIV-1) proteins for CD8+ and CD4+ cell responses has not been defined. METHODS:HIV-1-specific T cell responses were evaluated in 65 chronically HIV-1-infected untreated subjects by interferon- gamma flow cytometry with peptides spanning the clade C consensus sequence. RESULTS: The magnitude of HIV-1-specific CD8+ T cell responses correlated significantly with CD4+ cell responses, but the percentage of CD8+ T cells directed against HIV-1 (median, 2.76%) was always greater than that of CD4+ cells (median, 0.24%). Although CD8+ T cell responses were equally distributed among Gag, Pol, and the regulatory and accessory proteins, Gag was the dominant target for CD4+ cell responses. There was no consistent relationship between virus-specific CD8+ or CD4+ cell response and viral load. However, the median viral load in subjects in whom Gag was the dominant CD8+ T cell target was significantly lower than that in subjects in whom non-Gag proteins were the main target (P=.007). CONCLUSIONS:Gag-specific responses dominate the CD4+ T cell response to HIV, whereas CD8+ T cell responses are broadly distributed, which indicates differential immunogenicity of these cells against HIV-1. The preferential targeting of Gag by CD8+ T cells is associated with enhanced control of viral load.
Authors: Amy W Chung; Jenniffer M Mabuka; Bongiwe Ndlovu; Anna Licht; Hannah Robinson; Yathisha Ramlakhan; Musie Ghebremichael; Tarylee Reddy; Philip J R Goulder; Bruce D Walker; Thumbi Ndung'u; Galit Alter Journal: AIDS Date: 2018-06-19 Impact factor: 4.177
Authors: Vladimir Novitsky; Rui Wang; Jeannie Baca; Lauren Margolin; Mary F McLane; Sikhulile Moyo; Erik van Widenfelt; Joseph Makhema; M Essex Journal: Virology Date: 2011-10-19 Impact factor: 3.616
Authors: Brandon L Guthrie; Barbara Lohman-Payne; Amy Y Liu; Rose Bosire; Samuel Victor Nuvor; Robert Y Choi; Romel D Mackelprang; James N Kiarie; Stephen C De Rosa; Barbra A Richardson; Grace C John-Stewart; Carey Farquhar Journal: Clin Vaccine Immunol Date: 2012-09-12
Authors: Rosario Zuñiga; Aldo Lucchetti; Patricia Galvan; Shyla Sanchez; Carmen Sanchez; Ana Hernandez; Hugo Sanchez; Nicole Frahm; Caitlyn H Linde; Hannah S Hewitt; William Hildebrand; Marcus Altfeld; Todd M Allen; Bruce D Walker; Bette T Korber; Thomas Leitner; Jorge Sanchez; Christian Brander Journal: J Virol Date: 2006-03 Impact factor: 5.103
Authors: Sharon Shalekoff; Stephen Meddows-Taylor; Glenda E Gray; Gayle G Sherman; Ashraf H Coovadia; Louise Kuhn; Caroline T Tiemessen Journal: AIDS Date: 2009-04-27 Impact factor: 4.177
Authors: Vladimir Novitsky; Rui Wang; Lauren Margolin; Jeannie Baca; Lemme Kebaabetswe; Raabya Rossenkhan; Caitlin Bonney; Michaela Herzig; David Nkwe; Sikhulile Moyo; Rosemary Musonda; Elias Woldegabriel; Erik van Widenfelt; Joseph Makhema; Stephen Lagakos; M Essex Journal: PLoS One Date: 2009-11-05 Impact factor: 3.240